Other research studies suggested that TLR4 is involved in many inflammatory diseases such as influenza, cancer, diabetes, and neurodegenerative diseases, thereby suggesting that its regulation (antagonism/inhibition) would have an impressive clinical impact. The gene discussed is TLR4; the disease is diabetes mellitus.